粘性血小板综合征是导致反复流产的原因:一个罕见的病例报告
Dedy Kristofer Simangunsong1, Alvina Widhani, Ardhi Rahman Ahani
1Cipto Mangunkusumo Hospital, Jakarta, Indonesia. dedyked@gmail.com.
Acta medica Indonesiana
|April 22, 2025
概括
粘性血小板综合征 (SPS) 是一种遗传性疾病,可以导致经常性流产. 早期诊断和用克洛皮多格雷尔和维生素D3补充剂的治疗使一个有过多次流产病史的患者能够成功怀孕.
科学领域:
- 生殖医学 生殖医学
- 血液学 血液学 血液学
- 遗传学 遗传学 是一个
背景情况:
- 粘性血小板综合征 (SPS) 是一种遗传性出血障碍.
- 已知SPS是导致重复流产的原因之一,特别是在头三个月.
- 有效的管理策略可以减轻与SPS相关的流产风险.
研究的目的:
- 报告一个先前未被诊断的SPS.患者成功管理怀孕的病例.
- 突出在第一季度经常性流产的情况下考虑SPS的重要性.
- 为了证明克洛皮多格雷尔和维生素D3在怀孕期间管理SPS的有效性.
主要方法:
- 评估了一名33岁的妇女,她有五次流产的历史.
- 进行了标准的妇科,传染病,荷尔蒙,代谢和自身免疫治疗.
- 血小板聚合测试确定了SPS,并且还注意到维生素D缺乏.
- 治疗包括克洛皮多格勒和维生素D3补充剂.
主要成果:
- 初步对重复流产的调查没有显著的结果,除了维生素D缺乏和SPS.
- 在用克洛皮多格雷尔和维生素D3治疗后,患者成功怀孕.
- 怀孕进展到满期 (40周),没有任何母亲或胎儿并发症.
结论:
- 在复发性流产的差异诊断中,应考虑SPS.
- 及时诊断和适当的治疗,包括抗血小板治疗和维生素D补充,可以导致SPS妇女的成功妊娠结果.
- 这一案例凸显了对无法解释的反复流产进行全面诊断方法的重要性.
相关概念视频
Formation of the Platelet Plug
2.8K
The platelet phase, the second stage of hemostasis, commences around 15-20 seconds after an injury. It follows and overlaps with the vascular phase, during which blood vessels constrict to minimize blood loss.
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...
2.8K
Disorders of Hemostasis
638
Hemostasis, the process that stops bleeding after a blood vessel injury, is crucial for maintaining the integrity of the circulatory system. However, disorders of hemostasis can disrupt this delicate balance, leading to either excessive clotting or bleeding. These disorders can be broadly classified into thromboembolic disorders and bleeding disorders.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
638
Structure and Function of Platelets
879
The cell fragments known as platelets are disc-shaped, with an average diameter of about 3 μm and a thickness of roughly 1 μm. They play a crucial role in the body's vascular clotting system, which also involves plasma proteins, blood cells, and blood vessel tissues.
Platelets are continually replenished, circulating in the bloodstream for 9-12 days before being removed by phagocytes, primarily in the spleen. A microliter of circulating blood contains between 150,000 and 450,000...
Platelets are continually replenished, circulating in the bloodstream for 9-12 days before being removed by phagocytes, primarily in the spleen. A microliter of circulating blood contains between 150,000 and 450,000...
879
Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors
388
Antiplatelet drugs emerge as frontline defenders against the insidious threat of thromboembolic diseases, where abnormal clots obstruct vital blood vessels. These drugs stand as bulwarks, inhibiting platelet aggregation and clot formation, thereby mitigating the risk of life-threatening conditions like myocardial infarction, coronary artery disease, and thrombotic strokes.
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
388
Anticoagulant Drugs: Low-Molecular-Weight Heparins
545
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
545
Clot Retraction and Fibrinolysis
2.5K
After a fibrin clot is formed, the next step is clot retraction, a vital process facilitated by platelet contractile proteins, such as actin and myosin. These proteins pull the fibrin strands closer together and condense the clot. This action reduces the size of the clot, creating a smaller, denser structure that effectively seals off the damaged vessel. Clot retraction consolidates the clot and helps with wound healing by bringing the edges of the damaged blood vessel closer together.
2.5K


